Skin studies and their limits
GHK occurs naturally in the body. That fact does not establish the safety of injecting GHK-Cu or prove a benefit from a particular preparation. The form, route, and setting of a study remain essential details.
A 2015 skin-biology review describes laboratory findings involving collagen and other materials around cells. Collagen is a structural protein that helps give skin and other tissues strength. The review also discusses small topical studies, whose limitations matter when a claim moves from cell activity to visible changes in skin.
Several frequently repeated cosmetic findings come from limited reports rather than large, fully published clinical trials. The 2025 review of topical GHK delivery describes the shortage of strong clinical evidence. The record does not support a broad claim that copper peptides reverse aging throughout the body.
A preparation has to reach the relevant tissue
Skin is a barrier. An ingredient showing activity in a dish may not reach the same place or concentration when applied to intact skin. That makes delivery part of the scientific question, rather than a detail that can be ignored.
In laboratory work using human skin samples, researchers measured the passage and retention of copper applied as a tripeptide complex. This was work on removed skin, not a trial measuring cosmetic benefit in living participants. Detecting copper in a layer does not by itself show a useful change in appearance or health.
The topical delivery review examines how formulation affects passage through skin. A finding about one preparation cannot establish how another behaves. This site describes that limitation without supplying a routine for combining products or changing how they are applied.
Hair findings involved a combination
A 2016 study involving forty-five men with pattern hair loss tested GHK without copper together with another active ingredient. Hair counts increased more with the combination than with placebo. The study did not isolate an effect of GHK-Cu.
The distinction is easy to lose in a short claim about copper peptides and hair. A mixture's result cannot be assigned entirely to one ingredient, especially when the named ingredient is in a different chemical form. The trial also does not establish a benefit from injected GHK-Cu.
Laboratory and computer analyses of gene activity raise other research questions. A 2018 review discusses those findings. Changes in gene expression in a dataset or cells are not demonstrations that a person's biological age has been reversed.
Safety depends on route and context
Topical cosmetic use and injection expose the body differently. Small topical studies cannot establish the safety of systemic use. Long-term human effects and the way injected GHK-Cu moves through the body remain inadequately characterized.
FDA's safety-risk page current as of April 22, 2026 specifically identifies injectable GHK-Cu among substances with withdrawn nominations. It notes potential immune reactions associated with aggregation and peptide impurities, along with limited human safety data. This is not a statement that ordinary topical cosmetics and injections share the same regulatory status.
Copper handling is another relevant question. GHK-Cu has not been adequately studied in people with disorders such as Wilson disease, which causes copper to accumulate. Concern about repeated systemic exposure is theoretical; the evidence discussed here does not establish human copper poisoning caused by GHK-Cu.
Cosmetics and drug approval
No FDA-approved GHK-Cu medicine is established by the sources on this page. Cosmetics generally do not undergo FDA approval before sale. The FDA explanation of cosmetic regulation describes the distinction. A familiar cosmetic ingredient name is not evidence that an injected preparation is an approved drug.
Withdrawal of an injectable GHK-Cu nomination is also not clearance or permission to compound. A useful conversation about a proposed use begins with the route, the precise preparation, and the human evidence for the intended outcome. The study comparison shows why skin, hair, and repair findings cannot be collapsed into one general benefit.